These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25683856)

  • 1. High fluorescence in situ hybridization percentage of deletion 11q in patients with chronic lymphocytic leukemia is an independent predictor of adverse outcome.
    Jain P; Keating M; Thompson PA; Trinh L; Wang X; Wierda W; Ferrajoli A; Burger J; Kantarjian H; Estrov Z; Abruzzo L; O'Brien S
    Am J Hematol; 2015 Jun; 90(6):471-7. PubMed ID: 25683856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience.
    Van Dyke DL; Werner L; Rassenti LZ; Neuberg D; Ghia E; Heerema NA; Dal Cin P; Dell Aquila M; Sreekantaiah C; Greaves AW; Kipps TJ; Kay NE
    Br J Haematol; 2016 Apr; 173(1):105-13. PubMed ID: 26848054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing patients with multiple chromosomal aberrations detected by FISH in chronic lymphocytic leukemia.
    González-Gascón Y Marín I; Hernández-Sanchez M; Rodríguez-Vicente AE; Puiggros A; Collado R; Luño E; González T; Ruiz-Xivillé N; Ortega M; Gimeno E; Muñoz C; Infante MS; Delgado J; Vargas MT; González M; Bosch F; Espinet B; Hernández-Rivas JM; Hernández JÁ;
    Leuk Lymphoma; 2018 Mar; 59(3):633-642. PubMed ID: 28728469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lymphocytic leukemia with del13q14 as the sole abnormality: dynamic prognostic estimate by interphase-FISH.
    Orlandi EM; Bernasconi P; Pascutto C; Giardini I; Cavigliano PM; Boni M; Zibellini S; Cazzola M
    Hematol Oncol; 2013 Sep; 31(3):136-42. PubMed ID: 23060227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin heavy chain (IGH@) translocations negatively impact treatment-free survival for chronic lymphocytic leukemia patients who have an isolated deletion 13q abnormality.
    Gerrie AS; Bruyere H; Chan MJ; Dalal CB; Ramadan KM; Huang SJ; Toze CL; Gillan TL
    Cancer Genet; 2012 Oct; 205(10):523-7. PubMed ID: 22939229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late appearance of the 11q22.3-23.1 deletion involving the ATM locus in B-cell chronic lymphocytic leukemia and related disorders. Clinico-biological significance.
    Cuneo A; Bigoni R; Rigolin GM; Roberti MG; Bardi A; Cavazzini F; Milani R; Minotto C; Tieghi A; Della Porta M; Agostini P; Tammiso E; Negrini M; Castoldi G
    Haematologica; 2002 Jan; 87(1):44-51. PubMed ID: 11801464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosomal translocations independently predict treatment failure, treatment-free survival and overall survival in B-cell chronic lymphocytic leukemia patients treated with cladribine.
    Van Den Neste E; Robin V; Francart J; Hagemeijer A; Stul M; Vandenberghe P; Delannoy A; Sonet A; Deneys V; Costantini S; Ferrant A; Robert A; Michaux L
    Leukemia; 2007 Aug; 21(8):1715-22. PubMed ID: 17541398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A high proportion of cells carrying trisomy 12 is associated with a worse outcome in patients with chronic lymphocytic leukemia.
    González-Gascón Y Marín I; Hernández-Sánchez M; Rodríguez-Vicente AE; Sanzo C; Aventín A; Puiggros A; Collado R; Heras C; Muñoz C; Delgado J; Ortega M; González MT; Marugán I; de la Fuente I; Recio I; Bosch F; Espinet B; González M; Hernández-Rivas JM; Hernández JÁ; ;
    Hematol Oncol; 2016 Jun; 34(2):84-92. PubMed ID: 25689772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Low Frequency of Losses in 11q Chromosome Is Associated with Better Outcome and Lower Rate of Genomic Mutations in Patients with Chronic Lymphocytic Leukemia.
    Hernández JÁ; Hernández-Sánchez M; Rodríguez-Vicente AE; Grossmann V; Collado R; Heras C; Puiggros A; Martín AÁ; Puig N; Benito R; Robledo C; Delgado J; González T; Queizán JA; Galende J; de la Fuente I; Martín-Núñez G; Alonso JM; Abrisqueta P; Luño E; Marugán I; González-Gascón I; Bosch F; Kohlmann A; González M; Espinet B; Hernández-Rivas JM;
    PLoS One; 2015; 10(11):e0143073. PubMed ID: 26630574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetic abnormalities predict treatment-free interval and response to therapy in previously untreated chronic lymphocytic leukemia patients.
    Giertlova M; Hajikova M; Vaskova J; Kafkova A; Stecova N; Mirossay L; Karabinos A; Tothova E; Sarissky M
    Neoplasma; 2011; 58(1):82-8. PubMed ID: 21067270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.
    Marasca R; Maffei R; Martinelli S; Fiorcari S; Bulgarelli J; Debbia G; Rossi D; Rossi FM; Rigolin GM; Martinelli S; Gattei V; Del Poeta G; Laurenti L; Forconi F; Montillo M; Gaidano G; Luppi M
    Hematol Oncol; 2013 Jun; 31(2):88-95. PubMed ID: 23027683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic aberrations and survival in chronic lymphocytic leukemia.
    Döhner H; Stilgenbauer S; Benner A; Leupolt E; Kröber A; Bullinger L; Döhner K; Bentz M; Lichter P
    N Engl J Med; 2000 Dec; 343(26):1910-6. PubMed ID: 11136261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telomere shortening associated with increased genomic complexity in chronic lymphocytic leukemia.
    Dos Santos P; Panero J; Palau Nagore V; Stanganelli C; Bezares RF; Slavutsky I
    Tumour Biol; 2015 Nov; 36(11):8317-24. PubMed ID: 26008147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort.
    Davids MS; Vartanov A; Werner L; Neuberg D; Dal Cin P; Brown JR
    Br J Haematol; 2015 Sep; 170(5):694-703. PubMed ID: 26032737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with chronic lymphocytic leukaemia and clonal deletion of both 17p13.1 and 11q22.3 have a very poor prognosis.
    Greipp PT; Smoley SA; Viswanatha DS; Frederick LS; Rabe KG; Sharma RG; Slager SL; Van Dyke DL; Shanafelt TD; Tschumper RC; Zent CS
    Br J Haematol; 2013 Nov; 163(3):326-33. PubMed ID: 24032430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia.
    Durak B; Akay OM; Aslan V; Ozdemir M; Sahin F; Artan S; Gülbas Z
    Cancer Genet Cytogenet; 2009 Jan; 188(2):65-9. PubMed ID: 19100507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cumulative experience and long term follow-up of pentostatin-based chemoimmunotherapy trials for patients with chronic lymphocytic leukemia.
    Kay NE; LaPlant BR; Pettinger AM; Call TG; Leis JF; Ding W; Parikh SA; Conte MJ; Bowen DA; Shanafelt TD
    Expert Rev Hematol; 2018 Apr; 11(4):337-349. PubMed ID: 29460654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clonal evolution as detected by interphase fluorescence in situ hybridization is associated with worse overall survival in a population-based analysis of patients with chronic lymphocytic leukemia in British Columbia, Canada.
    Huang SJ; Bergin K; Smith AC; Gerrie AS; Bruyere H; Dalal CB; Sugioka DK; Hrynchak M; Ramadan KM; Karsan A; Gillan TL; Toze CL
    Cancer Genet; 2017 Jan; 210():1-8. PubMed ID: 28212806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13q14 deletion size and number of deleted cells both influence prognosis in chronic lymphocytic leukemia.
    Dal Bo M; Rossi FM; Rossi D; Deambrogi C; Bertoni F; Del Giudice I; Palumbo G; Nanni M; Rinaldi A; Kwee I; Tissino E; Corradini G; Gozzetti A; Cencini E; Ladetto M; Coletta AM; Luciano F; Bulian P; Pozzato G; Laurenti L; Forconi F; Di Raimondo F; Marasca R; Del Poeta G; Gaidano G; Foà R; Guarini A; Gattei V
    Genes Chromosomes Cancer; 2011 Aug; 50(8):633-43. PubMed ID: 21563234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic Lymphocytic Leukemia Patients With Deletion 11q Have a Short Time to Requirement of First-Line Therapy, But Long Overall Survival: Results of a Population-Based Cohort in British Columbia, Canada.
    Goy J; Gillan TL; Bruyere H; Huang SJT; Hrynchak M; Karsan A; Ramadan K; Connors J; Toze CL; Gerrie AS
    Clin Lymphoma Myeloma Leuk; 2017 Jun; 17(6):382-389. PubMed ID: 28559149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.